VIENNA, 03-Mar-2016 — /EuropaWire/ — Toshiba Medical Systems Europe is launching the Innovation 2016 upgrade for the Aplio Platinum line of ultrasound systems – an impressive portfolio of premium features assembled over the past 12 months – and visitors to the ECR (European Congress of Radiology) March 2-6 in Vienna will get a first-hand look and feel at the company’s leading-edge technologies.
Assembled as a toolkit for clinicians, Innovation 2016 upgrade brings new capabilities to radiologists using the Aplio Platinum line in everyday practices, including 3D Superb Micro-Vascular Imaging (SMI), 3D Shear Wave Elastography, Fusion Imaging and Real-Time 3D Needle Tracking.
“Providing these enhancements delivers on Toshiba’s commitment to putting customers first by continuously adding value to the existing platform through upgrades with the most advanced technology available”, said Christoph Simm, Ultrasound Business Manager of Toshiba Medical Systems Europe.
SMI is considered a game-changer since it allows clinicians to see smaller vessels in and around tumors, inflamed tissues, lymph nodes and other structures because of visualization of low velocity flow far beyond the conventional Doppler techniques. Significantly, visualization of microvasculature is improved without the need for contrast agents.
Another important feature is enhanced Smart Fusion imaging on the Aplio 500 Platinum Series combined with the new Real-Time 3D Needle Tracking. The combination can greatly extend a clinic’s ability to respond to increasing demand for biopsies and ablations of tumors. Once the CT or MRI data is loaded into the Aplio system, the image-fusion guided procedure can be performed under real-time ultrasound control in a very convenient and quick set-up wherever a patient can be correctly positioned. There is no longer a need to wait for a theater with an intraoperative CT or MRI when using Smart Fusion imaging and Real-Time 3D Needle Tracking.
Shear Wave Elastography has been integrated into the Aplio Platinum platform, making a significant clinical impact by adding unique features for mapping and quantifying tissue elasticity via shear wave propagation. Clinicians are able to better diagnose and document disease because the new enhancement displays simultaneous views of the shear wave propagation in a region of interest with the absolute value of elasticity, giving them confidence in the quality and reliability of the exam. In the Innovation 2016 version, shear wave elasticity maps can be measured even in 3D.
About Toshiba Medical Systems Europe
With headquarters in Zoetermeer, The Netherlands, Toshiba Medical Systems Europe (TMSE) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in Europe. For more information, visit the TMSE website at http://toshiba-medical.eu
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at http://www.toshibamedicalsystems.com
Toshiba Corporation, a Fortune Global 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future”, Toshiba promotes global operations and is contributing to the realization of a world where generations to come can live better lives.
Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 580 consolidated companies employing 199,000 people worldwide, with annual sales surpassing 6.6 trillion yen (US$55 billion). To find out more about Toshiba, visit http://www.toshiba.co.jp
SOURCE: Toshiba Medical Systems Europe B.V.